Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition

Medicine and Dentistry

• Pancreas Adenocarcinoma 100%
• Mesenchymal-Epithelial Transition 80%
• down Regulation 50%
• Marker 40%
• Transforming Growth Factor Beta1 40%
• Patient 30%
• Pancreatic Stellate Cell 30%
• Cells 20%
• Phenotype 20%
• Cancer Cell 10%
• Malignant Neoplasm 10%
• Therapeutic Procedure 10%
• In Vitro 10%
• Cell Proliferation 10%
• Lesion 10%
• Cell Migration 10%
• Clinical Significance 10%
• Prognostic Factor 10%
• Cell Invasion 10%
• Pancreas 10%
• Family 10%
• Colony Formation 10%
• Uvomorulin 10%
• Neutralizing Antibody 10%
• Cancer Growth 10%
• Small Interfering RNA 10%
• Precursor 10%
• Vimentin 10%
• Pancreas Adenoma 10%
• Adverse Outcome 10%
• Cancer Control 10%
• Protein Disulfide Isomerase 10%
• Adenocarcinoma Cell Line 10%
• Transforming Growth Factor Beta Receptor 1 10%

Biochemistry, Genetics and Molecular Biology

• Mesenchymal-Epithelial Transition 80%
• down Regulation 50%
• Transforming Growth Factor Beta 50%
• Stellate Cell 30%
• Phenotype 20%
• Cancer Cell 10%
• Precursor 10%
• Cell Proliferation 10%
• Cell Migration 10%
• Cell Invasion 10%
• Colony Formation 10%
• Neutralizing Antibody 10%
• Small Interfering RNA 10%
• Cadherin 10%
• Vimentin 10%
• Protein Disulfide-Isomerase 10%